Muscle biopsy abnormalities differ between Charcot-Marie-Tooth type 1 and 2: reflect different pathophysiology?

Area of Science:

• Neurology
• Muscle Biology
• Nerve Regeneration

Background:

• Charcot-Marie-Tooth (CMT) disease is a group of inherited disorders affecting peripheral nerves.
• CMT is classified into demyelinating (CMT 1) and axonal (CMT 2) forms, each with distinct pathological features.
• Understanding the underlying mechanisms of CMT subtypes is crucial for developing targeted therapies.

Purpose of the Study:

• To differentiate the pathological findings in muscle biopsies between Charcot-Marie-Tooth disease Type 1 and Type 2.
• To investigate the neurophysiological differences, particularly regarding denervation-reinnervation processes, in CMT 1 and CMT 2 patients.
• To elucidate the compensatory mechanisms employed by patients with CMT 2 to manage motor unit loss.

Main Methods:

• Analysis of muscle biopsy specimens to identify neuropathic and myopathic changes.
• Performance of neurophysiological studies to assess nerve function and reinnervation capacity.
• Correlation of pathological findings with clinical presentation and disease type.

Main Results:

• Muscle biopsies revealed neuropathic findings in Charcot-Marie-Tooth disease Type 1 (demyelinating form).
• Myopathic findings were observed in Charcot-Marie-Tooth disease Type 2 (axonal form).
• Neurophysiological studies indicated an active denervation-reinnervation process in CMT 1, while CMT 2 patients exhibited low reinnervation capacity and compensatory increases in contractile tissue.

Conclusions:

• Distinct muscle biopsy and neurophysiological profiles differentiate CMT 1 and CMT 2.
• CMT 1 is characterized by active nerve repair, whereas CMT 2 involves limited nerve regeneration and muscle hypertrophy.
• These findings highlight the divergent pathophysiological pathways in CMT subtypes and inform potential therapeutic strategies.